HERON THERAPEUTICS, INC. /DE/ Investing Cash Flow
HERON THERAPEUTICS, INC. /DE/ (HRTX) reported Investing Cash Flow of -$4.20 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Investing Activities
us-gaap:NetCashProvidedByUsedInInvestingActivities · last filed 2026-08-10
- HERON THERAPEUTICS, INC. /DE/ net cash provided by (used in) investing activities for the quarter ending 2026-06-30 was -$3.27M, a 144.52% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ net cash provided by (used in) investing activities for the quarter ending 2026-03-31 was -$939.00K, a 141.31% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ net cash provided by (used in) investing activities for the quarter ending 2025-12-31 was -$5.46M, a 147.78% decline year-over-year.
- HERON THERAPEUTICS, INC. /DE/ net cash provided by (used in) investing activities for the quarter ending 2025-09-30 was $11.86M, a 198.69% increase year-over-year.
- HERON THERAPEUTICS, INC. /DE/ net cash provided by (used in) investing activities for fiscal 2025 was $16.01M, a 14.45% decline from fiscal 2024.
- HERON THERAPEUTICS, INC. /DE/ net cash provided by (used in) investing activities for fiscal 2024 was $18.71M, a 4.00% increase from fiscal 2023.
- HERON THERAPEUTICS, INC. /DE/ net cash provided by (used in) investing activities for fiscal 2023 was $18.00M.
- HERON THERAPEUTICS, INC. /DE/ net cash provided by (used in) investing activities for fiscal 2022 was -$3.32M, a 110.16% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Investing Activities 3 month | Net Cash Provided by (Used in) Investing Activities 6 month | Net Cash Provided by (Used in) Investing Activities 9 month | Net Cash Provided by (Used in) Investing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$3.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$4.20M 10-Q · filed 2026-08-10 | -$9.66M derived: sum of 3 quarters · filed 2026-08-10 | $2.20M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | -$939.00K 10-Q · filed 2026-05-11 | -$6.39M derived: sum of 2 quarters · filed 2026-05-11 | $5.46M derived: sum of 3 quarters · filed 2026-05-11 | $12.80M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | -$5.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $6.40M derived: sum of 2 quarters · filed 2026-02-26 | $13.74M derived: sum of 3 quarters · filed 2026-08-10 | $16.01M 10-K · filed 2026-02-26 |
| 2025-09-30 | $11.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $19.19M derived: sum of 2 quarters · filed 2026-08-10 | $21.46M 10-Q · filed 2025-11-04 | $32.88M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-06-30 | $7.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $9.61M 10-Q · filed 2026-08-10 | $21.02M derived: sum of 3 quarters · filed 2026-08-10 | $25.00M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-03-31 | $2.27M 10-Q · filed 2026-05-11 | $13.69M derived: sum of 2 quarters · filed 2026-05-11 | $17.66M derived: sum of 3 quarters · filed 2026-05-11 | $19.71M derived: sum of 4 quarters · filed 2026-05-11 |
| 2024-12-31 | $11.42M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $15.39M derived: sum of 2 quarters · filed 2026-02-26 | $17.44M derived: sum of 3 quarters · filed 2026-02-26 | $18.71M 10-K · filed 2026-02-26 |
| 2024-09-30 | $3.97M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $6.02M derived: sum of 2 quarters · filed 2025-11-04 | $7.30M 10-Q · filed 2025-11-04 | -$1.54M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $2.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $3.33M 10-Q · filed 2025-08-08 | -$5.51M derived: sum of 3 quarters · filed 2026-02-26 | -$28.73M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.28M 10-Q · filed 2025-05-06 | -$7.56M derived: sum of 2 quarters · filed 2026-02-26 | -$30.78M derived: sum of 3 quarters · filed 2026-02-26 | -$17.56M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$8.84M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$32.06M derived: sum of 2 quarters · filed 2026-02-26 | -$18.84M derived: sum of 3 quarters · filed 2026-02-26 | $18.00M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$23.22M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$10.00M derived: sum of 2 quarters · filed 2024-11-12 | $26.83M 10-Q · filed 2024-11-12 | $28.85M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $13.22M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $50.05M 10-Q · filed 2024-08-06 | $52.07M derived: sum of 3 quarters · filed 2025-02-27 | $16.03M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $36.83M 10-Q · filed 2024-05-07 | $38.85M derived: sum of 2 quarters · filed 2025-02-27 | $2.81M derived: sum of 3 quarters · filed 2025-02-27 | $22.56M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $2.02M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$34.03M derived: sum of 2 quarters · filed 2025-02-27 | -$14.27M derived: sum of 3 quarters · filed 2025-02-27 | -$3.32M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$36.05M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | -$16.29M derived: sum of 2 quarters · filed 2023-11-14 | -$5.34M 10-Q · filed 2023-11-14 | -$29.60M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $19.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $30.70M 10-Q · filed 2023-08-14 | $6.44M derived: sum of 3 quarters · filed 2023-08-14 | $28.08M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $10.95M 10-Q · filed 2023-05-11 | -$13.31M derived: sum of 2 quarters · filed 2023-05-11 | $8.32M derived: sum of 3 quarters · filed 2023-05-11 | $48.02M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$24.26M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | -$2.62M derived: sum of 2 quarters · filed 2023-03-29 | $37.07M derived: sum of 3 quarters · filed 2023-03-29 | $32.73M 10-K · filed 2023-03-29 |
| 2021-09-30 | $21.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $61.33M derived: sum of 2 quarters · filed 2022-11-08 | $56.99M 10-Q · filed 2022-11-08 | $113.78M derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $39.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $35.35M 10-Q · filed 2022-08-09 | $92.14M derived: sum of 3 quarters · filed 2022-08-09 | $148.09M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | -$4.34M 10-Q · filed 2022-05-09 | $52.45M derived: sum of 2 quarters · filed 2022-05-09 | $108.39M derived: sum of 3 quarters · filed 2022-05-09 | $140.80M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $56.79M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $112.73M derived: sum of 2 quarters · filed 2022-02-28 | $145.14M derived: sum of 3 quarters · filed 2022-02-28 | $208.96M 10-K · filed 2022-02-28 |
| 2020-09-30 | $55.94M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $88.35M derived: sum of 2 quarters · filed 2021-11-03 | $152.17M 10-Q · filed 2021-11-03 | $25.81M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | $32.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $96.22M 10-Q · filed 2021-08-09 | -$30.14M derived: sum of 3 quarters · filed 2022-02-28 | -$1.51M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | $63.81M 10-Q · filed 2021-05-10 | -$62.54M derived: sum of 2 quarters · filed 2022-02-28 | -$33.92M derived: sum of 3 quarters · filed 2022-02-28 | $7.92M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$126.36M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$97.73M derived: sum of 2 quarters · filed 2022-02-28 | -$55.89M derived: sum of 3 quarters · filed 2022-02-28 | -$21.78M 10-K · filed 2022-02-28 |
| 2019-09-30 | $28.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-05 | $70.47M derived: sum of 2 quarters · filed 2020-11-05 | $104.58M 10-Q · filed 2020-11-05 | $112.90M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-06-30 | $41.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $75.95M 10-Q · filed 2020-08-05 | $84.28M derived: sum of 3 quarters · filed 2021-02-24 | -$64.98M derived: sum of 4 quarters · filed 2021-02-24 |
| 2019-03-31 | $34.11M 10-Q · filed 2020-05-06 | $42.44M derived: sum of 2 quarters · filed 2021-02-24 | -$106.82M derived: sum of 3 quarters · filed 2021-02-24 | -$204.15M derived: sum of 4 quarters · filed 2021-02-24 |
| 2018-12-31 | $8.33M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$140.93M derived: sum of 2 quarters · filed 2021-02-24 | -$238.26M derived: sum of 3 quarters · filed 2021-02-24 | -$278.55M 10-K · filed 2021-02-24 |
| 2018-09-30 | -$149.25M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$246.59M derived: sum of 2 quarters · filed 2019-11-12 | -$286.88M 10-Q · filed 2019-11-12 | -$307.24M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$97.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-05 | -$137.62M 10-Q · filed 2019-08-05 | -$157.99M derived: sum of 3 quarters · filed 2020-03-02 | -$87.38M derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$40.29M 10-Q · filed 2019-05-09 | -$60.66M derived: sum of 2 quarters · filed 2020-03-02 | $9.95M derived: sum of 3 quarters · filed 2020-03-02 | $12.36M derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | -$20.36M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $50.24M derived: sum of 2 quarters · filed 2020-03-02 | $52.66M derived: sum of 3 quarters · filed 2020-03-02 | $7.74M 10-K · filed 2020-03-02 |
| 2017-09-30 | $70.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | $73.02M derived: sum of 2 quarters · filed 2018-11-07 | $28.10M 10-Q · filed 2018-11-07 | $32.91M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-06-30 | $2.41M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | -$42.51M 10-Q · filed 2018-08-08 | -$37.70M derived: sum of 3 quarters · filed 2019-02-22 | -$68.85M derived: sum of 4 quarters · filed 2019-02-22 |
| 2017-03-31 | -$44.92M 10-Q · filed 2018-05-10 | -$40.11M derived: sum of 2 quarters · filed 2019-02-22 | -$71.26M derived: sum of 3 quarters · filed 2019-02-22 | -$52.70M derived: sum of 4 quarters · filed 2019-02-22 |
| 2016-12-31 | $4.81M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22 | -$26.34M derived: sum of 2 quarters · filed 2019-02-22 | -$7.78M derived: sum of 3 quarters · filed 2019-02-22 | $14.88M 10-K · filed 2019-02-22 |
| 2016-09-30 | -$31.15M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-06 | -$12.59M derived: sum of 2 quarters · filed 2017-11-06 | $10.06M 10-Q · filed 2017-11-06 | -$46.35M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-06-30 | $18.56M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $41.22M 10-Q · filed 2016-08-08 | -$15.20M derived: sum of 3 quarters · filed 2018-02-27 | -$15.45M derived: sum of 4 quarters · filed 2018-02-27 |
| 2016-03-31 | $22.66M 10-Q · filed 2016-05-05 | -$33.76M derived: sum of 2 quarters · filed 2018-02-27 | -$34.01M derived: sum of 3 quarters · filed 2018-02-27 | -$33.98M derived: sum of 4 quarters · filed 2018-02-27 |
| 2015-12-31 | -$56.42M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$56.67M derived: sum of 2 quarters · filed 2018-02-27 | -$56.63M derived: sum of 3 quarters · filed 2018-02-27 | -$56.96M 10-K · filed 2018-02-27 |
| 2015-09-30 | -$252.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-08 | -$214.00K derived: sum of 2 quarters · filed 2016-11-08 | -$542.00K 10-Q · filed 2016-11-08 | -$1.56M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $38.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | -$290.00K 10-Q · filed 2016-08-08 | -$1.31M derived: sum of 3 quarters · filed 2017-02-23 | -$1.39M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | -$328.00K 10-Q · filed 2016-05-05 | -$1.35M derived: sum of 2 quarters · filed 2017-02-23 | -$1.43M derived: sum of 3 quarters · filed 2017-02-23 | -$1.71M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | -$1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | -$1.10M derived: sum of 2 quarters · filed 2017-02-23 | -$1.38M derived: sum of 3 quarters · filed 2017-02-23 | -$1.44M 10-K · filed 2017-02-23 |
| 2014-09-30 | -$82.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | -$360.00K derived: sum of 2 quarters · filed 2015-11-06 | -$417.00K 10-Q · filed 2015-11-06 | -$584.00K derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-06-30 | -$278.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | -$335.00K 10-Q · filed 2015-08-07 | -$502.00K derived: sum of 3 quarters · filed 2016-02-19 | -$1.48M derived: sum of 4 quarters · filed 2016-02-19 |
| 2014-03-31 | -$57.00K 10-Q · filed 2015-05-08 | -$224.00K derived: sum of 2 quarters · filed 2016-02-19 | -$1.20M derived: sum of 3 quarters · filed 2016-02-19 | -$1.31M derived: sum of 4 quarters · filed 2016-02-19 |
| 2013-12-31 | -$167.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | -$1.14M derived: sum of 2 quarters · filed 2016-02-19 | -$1.25M derived: sum of 3 quarters · filed 2016-02-19 | -$1.69M 10-K · filed 2016-02-19 |
| 2013-09-30 | -$977.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | -$1.08M derived: sum of 2 quarters · filed 2014-11-06 | -$1.52M 10-Q · filed 2014-11-06 | -$1.94M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-06-30 | -$106.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | -$541.00K 10-Q · filed 2014-08-04 | -$967.00K derived: sum of 3 quarters · filed 2015-03-13 | -$1.05M derived: sum of 4 quarters · filed 2015-03-13 |
| 2013-03-31 | -$435.00K 10-Q · filed 2014-05-12 | -$861.00K derived: sum of 2 quarters · filed 2015-03-13 | -$940.00K derived: sum of 3 quarters · filed 2015-03-13 | -$984.00K derived: sum of 4 quarters · filed 2015-03-13 |
| 2012-12-31 | -$426.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-13 | -$505.00K derived: sum of 2 quarters · filed 2015-03-13 | -$549.00K derived: sum of 3 quarters · filed 2015-03-13 | -$972.00K 10-K · filed 2015-03-13 |
| 2012-09-30 | -$79.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-12 | -$123.00K derived: sum of 2 quarters · filed 2013-11-12 | -$546.00K 10-Q · filed 2013-11-12 | -$933.00K derived: sum of 4 quarters · filed 2014-03-07 |
| 2012-06-30 | -$44.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | -$467.00K 10-Q · filed 2013-08-08 | -$854.00K derived: sum of 3 quarters · filed 2014-03-07 | |
| 2012-03-31 | -$423.00K 10-Q · filed 2013-05-10 | -$810.00K derived: sum of 2 quarters · filed 2014-03-07 | ||
| 2011-12-31 | -$387.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-07 | -$513.00K 10-K · filed 2014-03-07 | ||
| 2011-09-30 | -$126.00K 10-Q · filed 2012-11-05 | |||
| 2010-12-31 | -$3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-01 | -$90.00K derived: sum of 2 quarters · filed 2013-03-01 | -$78.00K 10-K · filed 2013-03-01 | |
| 2010-09-30 | -$87.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | -$75.00K 10-Q · filed 2011-11-07 | ||
| 2010-06-30 | $12.00K 10-Q · filed 2011-08-08 | |||
| 2009-12-31 | $612.00K 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Lite Strategy, Inc. (LITS) | United States | $0.049B |